[Chemotaxis and phagocytosis of polymorphonuclear leukocytes in malnourished children]. 1977

A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk

Chemotactic activity of neutrophil polimorphonuclear cells, liberation of chemotactic factors by plasma proteins and phagocytic function of PMN cells by nitroblue tetrazolium reaction were evaluated in 20 malnourished children (from grade 1 through grade III) and in 20 normal children with similar age and sex, without any apparent infection. Also quantitative determination of immunoglobulins A, G and M and C3 complement fraction concentration in serum was made. Chemotactic and phagocytic activity were normal. Serum levels of Igs and C3 complement were within the lower limits of the normal range.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009580 Nitroblue Tetrazolium Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease. Nitro-BT,Nitrotetrazolium Blue,Tetrazolium Nitroblue,Blue, Nitrotetrazolium,Nitroblue, Tetrazolium,Tetrazolium, Nitroblue
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011502 Protein-Energy Malnutrition The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses. Marasmus,Protein-Calorie Malnutrition,Malnutrition, Protein-Calorie,Malnutrition, Protein-Energy,Malnutritions, Protein-Energy,Protein Calorie Malnutrition,Protein Energy Malnutrition
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3

Related Publications

A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
March 1968, Biochemical pharmacology,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
May 1978, The Journal of cell biology,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
January 1981, Archives of dermatological research,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
June 1979, The Journal of clinical investigation,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
October 1968, Science (New York, N.Y.),
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
April 1981, Infection and immunity,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
May 1992, New Jersey medicine : the journal of the Medical Society of New Jersey,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
March 1980, Israel journal of medical sciences,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
November 2011, Journal of leukocyte biology,
A González-Mendoza, and R Ramos-Zepeda, and G Farinatti, and M G Urbiola, and S Frenk
February 1984, Journal of medical microbiology,
Copied contents to your clipboard!